Nassir F Marrouche
Physician in Park City, UT
License number
Utah 5802748-8905
Issued Date
Aug 8, 2006
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Park City, UT
Personal information
See more information about Nassir F Marrouche at radaris.comName
Address
Phone
3293 Niblick Dr, Park City, UT 84098
Park City, UT
3293 Niblick Dr, Park City, UT 84098
Professional information
See more information about Nassir F Marrouche at trustoria.com
Therapeutic Success Prediction For Atrial Fibrillation
Therapeutic Success Prediction For Atrial Fibrillation
US Patent:
2010016, Jun 24, 2010
Filed:
Dec 24, 2008
Appl. No.:
12/344164
Inventors:
Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
International Classification:
A61B 5/055, A61B 5/02
US Classification:
600410, 600508
Abstract:
Certain embodiments of the invention provide methods of assessing a patient's risk for atrial fibrillation (AF) recurrence after receiving treatment with an AF treatment modality, that include determining, from left atrium (LA) tissue image data of a patient, a level of a parameter that is positively proportional to an amount of unhealthy tissue in a wall of the LA of the patient; and outputting, to an output device, an indicator of a comparison between (i) the determined level and (ii) a first threshold level of the parameter, the first threshold level derived from LA tissue image data of at least one other patient, who experienced an AF recurrence after treatment with the AF treatment modality. In certain embodiments, levels of the parameter equal to or greater than the first threshold level are indicative of a significant risk of AF recurrence after treatment with the AF treatment modality.
Therapeutic Outcome Assessment For Atrial Fibrillation
Therapeutic Outcome Assessment For Atrial Fibrillation
US Patent:
2010016, Jun 24, 2010
Filed:
Dec 24, 2008
Appl. No.:
12/344169
Inventors:
Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
Rob Macleod - Salt Lake City UT, US
Eugene Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
International Classification:
A61B 5/055, A61B 6/00, A61B 5/02
US Classification:
600420, 600431, 600508, 600407
Abstract:
Certain embodiments provide a method of assessing an outcome of an ablative atrial fibrillation (AF) treatment modality administered to a patient, the method including: determining, from left atrium (LA) tissue image data of a subject patient that has undergone an ablative AF treatment with the modality, at least one of: a level of a parameter that is positively proportional or negatively proportional to an amount of ablated tissue in a wall of the LA of the subject patient; and a spatial distribution, in the LA wall, of a variable indicative of ablated LA tissue; and outputting, to an output device, a machine-readable indicator of at least one of: (i) a comparison between the determined level and a threshold level of the parameter; and (ii) a map of the spatial distribution.
Image-Guided Renal Nerve Ablation
Image-Guided Renal Nerve Ablation
US Patent:
2013002, Jan 24, 2013
Filed:
Jun 15, 2012
Appl. No.:
13/525082
Inventors:
Nassir F. MARROUCHE - Park City UT, US
Dennis L. PARKER - Centerville UT, US
Dennis L. PARKER - Centerville UT, US
Assignee:
UNIVERSITY OF UTAH RESEARCH FOUNDATION - Salt Lake City UT
International Classification:
A61N 7/02
US Classification:
606 3
Abstract:
A method of treating hypertension in a mammal is described, including: by focused sound energy, heating at least one nerve at a surface of a renal artery in a mammal; during the heating and by magnetic resonance imaging, repeatedly determining thermal levels in each of first and second volumetric zones of a region that includes at least a portion of the surface, the second zone being adjacent to the first zone; after determining that an indicium of a thermal level in the first zone exceeds a first threshold, and upon determining that an indicium of a thermal level in the second zone exceeds a second threshold, ceasing the heating of the at least one nerve for at least three months; and as a result of the heating, lowering a blood pressure in the mammal.
Arrhythmia Information Management
Arrhythmia Information Management
US Patent:
2012021, Aug 23, 2012
Filed:
Feb 18, 2011
Appl. No.:
13/031068
Inventors:
Nassir F. MARROUCHE - Park City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61B 5/02
US Classification:
600508
Abstract:
Systems and methods for managing cardiac information concerning a patient are provided. In some aspects, cardiac information objects are displayed graphically at an interface having at least two axes. Time is displayed on a first axis of the at least two axes and parameters of the cardiac information objects are displayed on a second axis of the at least two axes. Each cardiac information object is spatially associated with at least a portion of the time displayed and a parameter displayed. In some aspects, the interface advantageously allows a user to conveniently view and manage the cardiac information objects.
Stroke Risk Assessment
Stroke Risk Assessment
US Patent:
2010029, Nov 25, 2010
Filed:
May 20, 2010
Appl. No.:
12/784487
Inventors:
Nassir F. Marrouche - Park City UT, US
Rob Macleod - Salt Lake City UT, US
Eugueni Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
Marcos Daccarett - Salt Lake City UT, US
Rob Macleod - Salt Lake City UT, US
Eugueni Kholmovski - Salt Lake City UT, US
Christopher McGann - Salt Lake City UT, US
Joshua Blauer - Bountiful UT, US
Troy Badger - Midvale UT, US
Robert Sillman Oakes - Centerville UT, US
Nathan Burgon - Sandy UT, US
Marcos Daccarett - Salt Lake City UT, US
International Classification:
A61B 5/055, A61B 5/00, A61B 6/00
US Classification:
600420, 600300, 600431
Abstract:
Certain embodiments provide a method of assessing a risk of thromboembolic stroke in a patient. The method comprises acquiring image data and determining an indicator of a degree of fibrosis of a patient's left atrium (LA) based on the image data. The method also comprises estimating a level of risk of thromboembolic stroke of the patient based on the indicator.